Login

Dr Stuart Quin, CEO of Medica Group PLC 00:00:00

Share On Facebook Share On Twitter

Dr Stuart Quin, CEO of Medica Group PLC, discusses the Group's first-half performance

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
From Humble Beginnings to Entrepreneurial Success: A Journey of Dreaming Big and Taking Risks| Robert Reffkin, CEO, Compass Inc.
00:00:00
Science Matters with Jeremy Gunawardena / Jeremy Gunawardena Associate Professor of Systems Biology, HMS
00:10:00
Entrepreneurial Wisdom Unveiled: Strategies for Success in Varied Industries and Collaborative Ventures | Richard Li, Chairman , PCCW
00:10:00
Professor Scott Yenor on Fraternity, Compulsory Feminism, and Civic Renewal|Scott Yenor,Professor,Boise State University
00:10:00
Insights into Oak Hill Advisors' Strategic Approach in Distressed and Private Credit Markets |Glenn August , CEO, Oak Hill Advisors.
00:10:00
The Blueprint to Investment Success: Key Behaviors for Achieving Your Goals | The Fearless Advisor, F5 Financial
00:10:00
Metso North Bay's Commitment to Safety, Lean Manufacturing, and Environmental Impact
00:10:00
Disclosure: Securities and Advisory Services through M Holdings Securities and Eslick Financial Group
00:10:00
Novel Cell Therapy Approaches for Oncology Highlight Manufacturing and Commercialization Strategies at Cell | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
American Lithium's Strategic Expansion and Key Milestones: Insights from CEO Simon Clark
00:10:00
Pnvestment firm committed to helping create incredible technology companies|Wilder Ramsey,Partner & Co-Founder,Toba Capital
00:10:00
Microsoft and ActiveOps Partnership explained | Richard Jeffery, CEO, ActiveOps PLCAOM:LSE

© 2017 - Neuhu+